Candel Therapeutics Mean Deviation
| CADL Stock | | | USD 8.35 0.56 7.19% |
The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns. Below is Candel Therapeutics's current Mean Deviation with peer comparisons and related risk metrics.
Current Mean Deviation Value
Candel Therapeutics registers a Mean Deviation of 3.57, reflecting moderate price variability. This places Candel Therapeutics within the typical volatility range for Biotechnology.
Mean Deviation | = | SUM(RET DEV)N |
| = | 3.57 | |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of Candel Therapeutics |
| N | = | Number of calculation points for selected time horizon |
Mean Deviation Peers Comparison
Candel Therapeutics's Mean Deviation of 3.57 falls below the 3.95 peer average. Values range from 2.87 (Contineum Therapeutics Class) to 5.16 (Aldeyra), with moderate dispersion across the group. Candel Therapeutics has exhibited less price dispersion than the peer average over the measured period.
Mean Deviation Relative To Other Indicators
The chart below plots Mean Deviation against Maximum Drawdown for Candel Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Mean Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
The Maximum Drawdown-to-Mean Deviation ratio for Candel Therapeutics sits near
8.71 , with Mean Deviation at
3.57 and Maximum Drawdown at
31.12 . This indicates Maximum Drawdown substantially exceeds Mean Deviation for Candel Therapeutics.
Methodology, Assumptions & Data Sources
Candel Therapeutics' Mean Deviation currently stands at 3.57. Mean Deviation for Candel Therapeutics is derived by applying a defined formula to historical price observations, producing a time-series of comparable readings. Price data is sourced from standardized end-of-day feeds across supported exchanges, normalized for corporate actions. Candel Therapeutics operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.
Other Technical Indicators